Closed
0.72 5.88
24h
Min
0.67
Max
0.74
Income | 44M 7.3M |
---|---|
Sales | 5.1M 29M |
EPS | -0.15 |
Profit margin | 24.888 |
Employees | 61 |
EBITDA | 48M 17M |
Recommendations | Buy |
---|---|
12 Months Forecast | +623.53% upside |
Next Earnings | 8 May 2025 |
---|
Market Cap | -51M 116M |
---|---|
Previous open | -5.16 |
Previous close | 0.72 |
By Trading Central
Confidence
Very Strong Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 4.92 USD 623.53%
High 7 USD
Low 2 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$